MetaCap

CVS Health Financial Ratios

NYSE: CVSConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD

86.16-1.64 (-1.87%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

CVS Health ratio analysis

CVS Health earned a net margin of 0.4% in FY 2025, down from 1.2% a year earlier. Gross margin was 45.0% compared with a median of 38.9% over the prior 9 years. Return on equity reached 2.4%, meaning CVS Health generated 0.02 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.86 versus 0.88 the year before, and the current ratio was 0.84. At the end of FY 2025, CVS traded at 57.6 times earnings; across the 9 fiscal years shown, its year-end P/E ranged from 11.3 to 57.6, with a median of 14.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

CVS Health financial ratios (annual)

CVS Health annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)57.6512.5112.2028.5917.1412.5114.48—11.2616.10
Price / sales0.250.150.280.380.470.330.370.360.400.48
Price / book1.350.761.331.711.811.291.501.201.962.30
Gross margin45.0%44.7%39.3%38.9%39.8%39.0%38.2%19.6%15.4%16.3%
Operating margin1.2%2.3%3.8%2.5%4.6%5.2%4.7%2.1%5.2%5.8%
Net margin0.4%1.2%2.3%1.3%2.7%2.7%2.6%-0.3%3.6%3.0%
Free cash flow margin1.9%1.7%2.9%4.2%5.4%5.0%4.0%3.5%3.3%4.5%
Return on equity (ROE)2.4%6.1%10.9%6.0%10.7%10.3%10.4%-1.0%17.6%14.4%
Return on assets (ROA)0.7%1.8%3.3%1.9%3.4%3.1%3.0%-0.3%7.0%5.6%
Debt / equity0.860.880.810.730.750.931.071.260.720.75
Current ratio0.840.810.860.950.880.910.941.031.021.18
Revenue growth7.8%4.2%10.9%10.4%8.7%4.6%32.0%5.3%4.1%15.8%
EPS growth-62.0%-43.4%98.5%-45.8%10.3%7.5%—-108.9%31.4%5.8%

Related